在结直肠癌中通过天然产品准铁灭调节剂
Yiping Zhang1,2, Jun Xie1,2
1School of Life Sciences, Fudan University, Shanghai, China.
Frontiers in pharmacology
|June 11, 2024
概括
天然产品通过向细胞死亡通路ferroptosis,为结直肠癌 (CRC) 提供了一种新的策略. 这些化合物在克服治疗耐药性和改善CRC患者治疗结果方面表现有前途.
科学领域:
- 在瘤学瘤学.
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 结肠直肠癌 (CRC) 是全球癌症死亡的主要原因.
- 目前的CRC治疗面临着诸如耐药性和有效性有限等挑战.
- 针对受调节的细胞死亡途径铁亡,呈现出一种新的治疗途径.
研究的目的:
- 审查天然产品,营养药品和植物化学品在针对CRC治疗中的铁灭调节者的潜力.
- 探索自然化合物如何在CRC细胞中诱导铁亡.
- 为自然产品调节与铁亡相关的蛋白质提供洞察力.
主要方法:
- 关于CRC中天然产品和铁亡的研究的文献综述.
- 针对关键铁灭调节剂 (例如GPX4,SLC7A11,ACSL4,NCOA4,HO-1) 的天然产品的分析.
- 探索代谢途径 (氨基酸,铁,脂质) 和氧化应激在ferroptosis诱导.
主要成果:
- 自然产品具有多样化的生物活性作用和有利的安全性.
- 这些化合物可以调节对铁亡至关重要的蛋白质,包括GPX4,SLC7A11,ACSL4,NCOA4和HO-1.
- 针对这些调节体提供了一种诱导癌细胞死亡的有希望的策略.
结论:
- 自然产品通过诱导铁亡,代表了结直肠癌的有希望的治疗策略.
- 对这些机制的进一步研究可以导致创新的CRC治疗方法.
- 这种方法可能有助于克服与当前CRC疗法相关的挑战.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.7K
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
11.3K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K